Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

chevron_leftPreviosly
OneVentures appoints new Venture Partner
07 May 2015
Nextchevron_right
Vaxxas Nanopatch on Channel 7 News and Today Tonight
23 February 2015

You may also like

17 December 2015

OneVentures’ Innovation and Growth Fund II hits $100 million in FUM

16 May 2018

Biomedical Translation Fund invests in further development of total artificial heart device

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

05 August 2018

Australian First:-Israeli venture partnership launches new Venture Credit Fund to invest in high-growth technology companies

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close